Evidence map›Paper›PMID 41294432›Full record

ArticleBiomimetics (Basel, Switzerland)2025

Multi-Strategy Improved POA for Global Optimization Problems and 3D UAV Path Planning.

Rui Zhang, Jingbo Zhan, Jianfeng Wang

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rui ZhangSchool of Engineering Science, Shandong Xiehe University, Jinan 250107, China.ORCID 0000-0003-0822-1513
Jingbo ZhanSchool of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China.
Jianfeng WangSouth Korea College of Design, Hanyang University, Ansan 15588, Gyeonggi-do, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of smart manufacturing and the low-altitude economy, drone technology-as a vital component of next-generation intelligent equipment-has garnered significant attention from researchers. Path planning, one of the core challenges in drone technology advancement, directly impacts the efficiency and safety of drone mission execution. However, most existing drone path planning algorithms suffer from issues such as requiring extensive interactive information or being prone to getting stuck in local optima. This study introduces a multi-strategy enhanced Pelican Optimization Algorithm (MIPOA) tailored for UAV path planning. To improve the quality of the initial population, a hybrid initialization approach combining low-discrepancy sequences with heuristic refinement is developed. The low-discrepancy component promotes a more uniform distribution across the search space, while the heuristic mechanism enhances the fitness of selected individuals and reduces redundant exploration. Furthermore, a subgroup mean-guided updating strategy is designed to accelerate convergence toward the global optimum. To maintain exploration ability, a random reinitialization boundary mechanism is incorporated, effectively preventing premature convergence. To validate the algorithm's performance, MIPOA is compared with eleven benchmark metaheuristics on the CEC2017 test suite, and statistical analyses confirm its superior optimization capability. Finally, MIPOA is applied to 3D UAV path planning under four threat scenarios in a realistic environment, demonstrating robust adaptability and achieving successful mission completion.

Indexed as

3D UAV path planningIEEE CEC2017intelligent optimization algorithmpelican optimization algorithm

Identifiers

PMID41294432
PMCPMC12650227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.